These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7273240)

  • 1. Cellular and chemical reduction products of misonidazole.
    Varghese AJ; Whitmore GF
    Chem Biol Interact; 1981 Aug; 36(2):141-51. PubMed ID: 7273240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding to cellular macromolecules as a possible mechanism for the cytotoxicity of misonidazole.
    Varghese AJ; Whitmore GF
    Cancer Res; 1980 Jul; 40(7):2165-9. PubMed ID: 6155991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misonidazole-glutathione conjugates in CHO cells.
    Varghese AJ; Whitmore GF
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1341-5. PubMed ID: 6540764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of nitroreduction products of misonidazole to nucleic acids and protein.
    Varghese AJ; Whitmore GF
    Cancer Clin Trials; 1980; 3(1):43-6. PubMed ID: 7389036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of a reactive metabolite of misonidazole in hypoxic mammalian cells.
    Varghese AJ; Whitmore GF
    Radiat Res; 1984 Feb; 97(2):262-71. PubMed ID: 6538047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of reduction products of misonidazole on Chinese hamster ovary cells.
    Middlestadt MV; Rauth AM
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):709-12. PubMed ID: 7107403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro metabolism of misonidazole.
    Josephy PD; Palcic B; Skarsgard LD
    Br J Cancer; 1981 Apr; 43(4):443-50. PubMed ID: 7236487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of guanine derivatives by reduced 2-nitroimidazoles.
    Varghese AJ; Whitmore GF
    Cancer Res; 1983 Jan; 43(1):78-82. PubMed ID: 6847786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione conjugates of misonidazole.
    Varghese AJ
    Biochem Biophys Res Commun; 1983 May; 112(3):1013-20. PubMed ID: 6847675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative misonidazole metabolism in anaerobic bacteria and hypoxic Chinese hamster lung fibroblast (V-79-473) cells.
    Koch RL; Rose C; Rich TA; Goldman P
    Biochem Pharmacol; 1982 Feb; 31(3):411-4. PubMed ID: 7073768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism induced binding of 14C-misonidazole to hypoxic cells: kinetic dependence on oxygen concentration and misonidazole concentration.
    Koch CJ; Stobbe CC; Baer KA
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1327-31. PubMed ID: 6469755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells.
    Chapman JD; Baer K; Lee J
    Cancer Res; 1983 Apr; 43(4):1523-8. PubMed ID: 6831401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic properties of hydroxylamino- and amino-misonidazole, possible metabolic products of misonidazole, in hypoxic HeLa S3 cells.
    Murayama C; Hori H; Mori T; Inayama S
    Gan; 1983 Oct; 74(5):693-8. PubMed ID: 6642142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reductive fragmentation of 2-nitroimidazoles in the presence of nitroreductases--glyoxal formation from misonidazole.
    Raleigh JA; Liu SF
    Biochem Pharmacol; 1983 Apr; 32(8):1444-6. PubMed ID: 6687998
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of hypoxia on the metabolism and excretion of misonidazole by the isolated perfused rat liver--a model system.
    Smith BR; Born JL; Garcia DJ
    Biochem Pharmacol; 1983 May; 32(10):1609-12. PubMed ID: 6860347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label.
    Raleigh JA; Franko AJ; Koch CJ; Born JL
    Br J Cancer; 1985 Feb; 51(2):229-35. PubMed ID: 3966980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioreductive metabolism of AF-2[2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide] combined with 2-nitroimidazoles. Implications for use as hypoxic cell markers.
    Koch CJ; Giandomenico AR; Iyengar CW
    Biochem Pharmacol; 1993 Sep; 46(6):1029-36. PubMed ID: 8216345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitro.
    Taylor YC; Rauth AM
    Br J Cancer; 1980 Jun; 41(6):892-900. PubMed ID: 7426314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reductive metabolism and DNA binding of misonidazole.
    Djuric Z
    Toxicol Appl Pharmacol; 1989 Oct; 101(1):47-54. PubMed ID: 2799816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of misonidazole by rat liver microsomes and purified NADPH-cytochrome c reductase.
    McManus ME; Lang MA; Stuart K; Strong J
    Biochem Pharmacol; 1982 Feb; 31(4):547-52. PubMed ID: 6802140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.